Penumbra (PEN) Other Non-Current Assets (2014 - 2026)
Penumbra's (PEN) quarterly Other Non-Current Assets came in at $41.0 million in Q1 2026, down 6.28% year-on-year from $43.7 million in Q1 2025, and up 0.66% on a QoQ basis from $40.7 million in Q4 2025.
Penumbra (PEN) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Other Non-Current Assets data on file, last reported at $41.0 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 6.28% year-over-year to $41.0 million in Q1 2026; TTM through Mar 2026 was $41.0 million, a 6.28% decrease from a year earlier, with the FY2025 full-year figure at $40.7 million, down 0.54% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $41.0 million, up from $40.7 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for PEN reached as high as $43.7 million in Q1 2025 and fell as low as $10.5 million in Q2 2023.
- Historically, Other Non-Current Assets has averaged $27.9 million across 5 years, with a median of $33.8 million in 2024.
- Across the five-year window, Other Non-Current Assets fell 24.84% in 2023 and surged 266.84% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $12.8 million in 2022, then soared by 102.3% to $25.9 million in 2023, then surged by 58.19% to $40.9 million in 2024, then dropped by 0.54% to $40.7 million in 2025, then increased by 0.66% to $41.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $41.0 million in Q1 2026, $40.7 million in Q4 2025, and $40.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 40.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.98 Mn |
| Dec 31, 2025 | 40.72 Mn |
| Sep 30, 2025 | 40.02 Mn |
| Jun 30, 2025 | 40.39 Mn |
| Mar 31, 2025 | 43.73 Mn |
| Dec 31, 2024 | 40.94 Mn |
| Sep 30, 2024 | 38.51 Mn |
| Jun 30, 2024 | 38.52 Mn |
| Mar 31, 2024 | 33.81 Mn |
| Dec 31, 2023 | 25.88 Mn |
| Sep 30, 2023 | 14.74 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 11.17 Mn |
| Dec 31, 2022 | 12.79 Mn |
| Sep 30, 2022 | 13.48 Mn |
| Jun 30, 2022 | 13.97 Mn |
| Mar 31, 2022 | 13.69 Mn |
| Dec 31, 2021 | 12.99 Mn |
| Sep 30, 2021 | 11.37 Mn |
| Mar 31, 2021 | 9.91 Mn |